Wow you got ripped off on that price. Buy PATH to make up for loss potential.
So you got a poor buyout of your MAKO? Should have been closer to $50-$60 range, but you got ripped off. Well check out PATH and the potential of partnership/buyout that could take this company with a FDA approved drug to 6-8 fold increase in a short time. Just do some DD on PATH to see if it is a fit, that's all.